Improving survival in neuro-oncology is a struggle; we cannot allow ourselves to also struggle with issues of diversity
- PMID: 35325224
- PMCID: PMC9340615
- DOI: 10.1093/neuonc/noac069
Improving survival in neuro-oncology is a struggle; we cannot allow ourselves to also struggle with issues of diversity
Comment on
-
A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.Neuro Oncol. 2022 Aug 1;24(8):1341-1349. doi: 10.1093/neuonc/noac011. Neuro Oncol. 2022. PMID: 34999844 Free PMC article.
References
-
- Chukwueke UN, Hervey-Jumper S, Porter A. Disparities and inequities among patients with central nervous system tumor. Hematol Oncol Clin North Am. 2022;36(1):e1–e8. - PubMed
-
- Bates AJ, Couillard SA, Arons DF, et al. Hout-15. Brain tumor patient and caregiver survey on clinical trials: identifying attitudes and barriers to patient participation. Neuro Oncol. 2017;19(Suppl 6):vi109.
-
- Rhome R, Fisher R, Hormigo A, Parikh RR. Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma. J Neurooncol. 2016;128(2):241–250. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
